Price Alert

CareDx Inc (CDNA)

NASDAQ: CDNA · Real-Time Price · USD

15.19

0.35 (2.36%)

At close: Oct 03, 2025, 2:29 PM

2.36% (1D)

Bid	11.03
Market Cap	808.65M
Revenue (ttm)	340.83M
Net Income (ttm)	51.68M
EPS (ttm)	1.05
PE Ratio (ttm)	14.47
Forward PE	-107.14
Analyst	Buy
Dividends	n/a

Ask	19.12
Volume	588,917
Avg. Volume (20D)	1,715,671
Open	14.89
Previous Close	14.84
Day's Range	14.83 - 15.48
52-Week Range	10.96 - 32.76
Beta	2.28
Ex-Dividend Date	n/a

About CDNA

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol CDNA

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CDNA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

CareDx Inc is scheduled to release its earnings on Nov 3, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

4 months ago

+10.67%

CareDx shares are trading higher after the company... Unlock content with Pro Subscription

7 months ago

+11.16%

CareDx shares are trading higher after Chevy Chase Trust CIO Amy Raskin disclosed on CNBC's Halftime Report that she has bought the stock.

News

1 month ago · benzinga.com

CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential

CareDx, Inc. CDNA faces fresh uncertainty as proposed reimbursement changes threaten its core testing business, clouding near-term growth even as the company's expanding transplant solutions platform ...

1 month ago · businesswire.com

CareDx to Participate in Wells Fargo Healthcare Conference

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinical...

1 month ago · fool.com

CareDx (CDNA) EPS Beats Sales Gain 14%

1 month ago · seekingalpha.com

CareDx, Inc (CDNA) Q2 2025 Earnings Call Transcript

CareDx, Inc (NASDAQ:CDNA ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Abhishek Jain - CFO & Principal Accounting Officer Caroline Corner - Corporate Participant Jo...

1 month ago · zacks.com

Here's What Key Metrics Tell Us About CareDx (CDNA) Q2 Earnings

The headline numbers for CareDx (CDNA) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates ...

1 month ago · zacks.com

CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates

CareDx (CDNA) came out with quarterly earnings of $0.1 per share, missing the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.25 per share a year ago.

1 month ago · businesswire.com

CareDx Announces Appointment of Nathan Smith as Chief Financial Officer

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinica...

1 month ago · businesswire.com

CareDx Announces Second Quarter 2025 Financial Results

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company - a leading precision medicine company focused on the discovery, development and commercialization of clinically...